List of Generic Drugs Stocks
Generic Drugs is part of the Pharmaceuticals and Biotechnology group in the Healthcare sector. Its 40 US-listed companies are worth $512.56 billion between them. The median is $185.14 million. 23 have Generic Drugs as their primary business, and 17 more run a substantial one alongside another industry.
|
List of Generic Drugs Stocks
|
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Symbol | Company | Mkt Cap | Price | Chg % | 1Y | Revenue (TTM) | Net Income (TTM) | P/E | Revenue Growth (1y) (TTM)% | Net Margin (TTM)% | Div. Yield% | Why this company is listed here |
| ABT 2nd | Abbott Laboratories | $174.73Bn | 100.98 | -0.33% | -24.14% | 46.59Bn | 5.43Bn | 32.40 | 8.06 | 11.65 | 2.46 | |
| PFE 2nd | Pfizer | $163.75Bn | 28.73 | +0.17% | +20.46% | 63.70Bn | 4.37Bn | 37.80 | -0.21 | 6.80 | 5.99 | |
| TEVA | Teva Pharmaceutical Industries | $45.31Bn | 38.88 | -0.77% | +102.71% | 17.32Bn | 709.00Mn | 64.16 | 4.13 | 4.08 | 0.00 | |
| BIIB 2nd | Biogen | $33.79Bn | 228.69 | +0.48% | +65.10% | 10.03Bn | 834.60Mn | 40.47 | 0.31 | 8.32 | — | |
| VTRS | Viatris | $20.98Bn | 18.27 | +2.47% | +89.92% | 14.74Bn | -410.70Mn | -51.75 | 4.40 | -2.79 | 2.63 | |
| CORT 2nd | Corcept Therapeutics | $12.50Bn | 115.63 | -0.40% | +37.82% | 830.81Mn | 55.23Mn | 224.80 | 16.02 | 6.52 | — | |
| BAX 2nd | Baxter International | $12.15Bn | 23.50 | +0.51% | +5.00% | 11.10Bn | -1.06Bn | -11.43 | 1.92 | -9.58 | 0.17 | |
| RDY | Dr Reddys Laboratories | $10.44Bn | 12.51 | +2.04% | -10.45% | 3.66Bn | 4.44Bn | 0.06 | -6.71 | 4,658.34 | 0.64 | |
| HIMS 2nd | Hims & Hers Health | $6.72Bn | 28.79 | -2.14% | -51.30% | 2.58Bn | -142.03Mn | -46.99 | 28.04 | -5.51 | — | |
| LQDA 2nd | Liquidia | $6.56Bn | 73.67 | +7.66% | +223.11% | 450.91Mn | 138.58Mn | 47.24 | 2,233.65 | 30.74 | — | |
| AMRX | Amneal Pharmaceuticals | $6.55Bn | 20.50 | +3.69% | +107.70% | 3.12Bn | 215.32Mn | 41.58 | 9.28 | 5.05 | — | |
| BLCO 2nd | Bausch & Lomb | $6.06Bn | 16.96 | +0.53% | +13.37% | 5.32Bn | -163.00Mn | -35.42 | 8.85 | -3.21 | — | |
| OGN 2nd | Organon | $3.61Bn | 13.73 | +0.00% | +32.66% | 6.13Bn | 209.00Mn | 17.25 | -2.45 | 3.41 | 0.58 | |
| BHC | Bausch Health Companies | $2.16Bn | 5.78 | +1.58% | -10.66% | 10.85Bn | -1.09Bn | -1.97 | 10.09 | -10.12 | 0.00 | |
| ALVO | Alvotech | $1.92Bn | 6.15 | +6.96% | -26.79% | 105.94Mn | -262.73Mn | -6.78 | — | -248.00 | — | |
| ANIP | Ani Pharmaceuticals | $1.78Bn | 74.83 | +1.12% | -18.60% | 978.38Mn | 108.31Mn | 14.66 | 30.90 | 11.04 | — | |
| HROW 2nd | Harrow | $1.18Bn | 31.60 | -4.45% | -34.71% | 275.59Mn | -33.46Mn | -31.71 | 21.05 | -13.51 | — | |
| AMPH | Amphastar Pharmaceuticals | $1.16Bn | 27.39 | +4.82% | +1.75% | 730.02Mn | 78.55Mn | 15.22 | 1.02 | 10.76 | — | |
| FENC | Fennec Pharmaceuticals | $383.62Mn | 10.95 | +3.30% | +20.46% | 53.77Mn | -4.44Mn | -57.28 | 61.45 | -12.28 | — | |
| SLGL 2nd | Sol-Gel Technologies | $193.50Mn | 69.45 | +3.89% | +141.65% | 1.80Mn | -10.49Mn | -21.78 | -92.50 | -494.87 | — | |
| DERM 2nd | Journey Medical | $176.78Mn | 6.43 | +4.72% | -9.44% | 68.18Mn | -6.10Mn | -28.96 | 20.89 | -8.95 | — | |
| NRXP 2nd | NRX Pharmaceuticals | $123.86Mn | 2.87 | -4.01% | -11.69% | 3.43Mn | -21.02Mn | -4.61 | — | -684.82 | — | |
| NTRB | NutriBand | $100.04Mn | 8.23 | +2.87% | +16.57% | 1.62Mn | -6.96Mn | -14.37 | -37.25 | -430.43 | — | |
| GRML | Greenland Mines | $29.99Mn | 11.85 | -19.17% | -53.16% | — | -21.77Mn | -1.38 | — | — | — | |
| BGM | Bgm | $27.18Mn | 0.24 | +0.00% | -97.50% | — | — | — | — | — | 0.00 | |
| ETST | Earth Science Tech | $25.88Mn | 0.09 | +0.00% | -47.06% | 35.96Mn | 3.86Mn | 6.71 | 7.96 | 10.82 | — | |
| NXPL | NextPlat | $24.55Mn | 9.05 | +0.44% | +10.37% | 48.29Mn | -8.61Mn | -2.49 | -17.82 | -20.38 | — | |
| AYTU 2nd | Aytu Biopharma | $23.58Mn | 2.17 | -4.82% | +26.90% | 57.57Mn | -14.25Mn | -1.88 | -13.27 | -24.76 | — | |
| COSM | Cosmos Health | $22.17Mn | 0.37 | +5.71% | -65.42% | 73.73Mn | -24.39Mn | -0.91 | 33.82 | -33.08 | — | |
| HIND 2nd | Vyome Holdings | $14.25Mn | 2.03 | -0.49% | -62.13% | 129.72K | -11.58Mn | -1.26 | -67.12 | -8,716.77 | — | |
| AEON | AEON Biopharma | $13.14Mn | 0.26 | +0.00% | -68.29% | — | -49.47Mn | -0.27 | — | — | — | |
| SCNX | Scienture Holdings | $11.09Mn | 0.27 | -3.57% | -67.86% | 410.22K | -16.02Mn | -0.67 | — | -3,902.57 | 0.00 | |
| RDHL | RedHill Biopharma | $7.53Mn | 0.51 | +2.00% | -78.21% | — | — | -308.05 | — | — | — | |
| MGRX 2nd | Mangoceuticals | $6.85Mn | 0.38 | -19.15% | -81.99% | 315.23K | -15.10Mn | -0.40 | -38.91 | -5,164.40 | — | |
| PMHS | Polomar Health Services | $4.81Mn | 0.17 | +13.33% | -15.00% | 3.17Mn | -9.46Mn | -0.50 | 7,688.77 | -301.11 | — | |
| SXTP | 60 Degrees Pharmaceuticals | $3.32Mn | 1.25 | +6.84% | -79.71% | 1.11Mn | -8.11Mn | -0.41 | 73.21 | -729.86 | — | |
| SBFM | Sunshine Biopharma | $1.12Mn | 0.82 | -2.38% | -94.34% | 35.35Mn | -5.83Mn | -0.19 | -2.74 | -16.50 | — | |
| PRFX | PRF Technologies | $628.53K | 0.97 | -1.02% | -86.34% | — | — | — | — | — | — | |
| QNRX | Quoin Pharmaceuticals | $496.70K | 5.26 | -18.20% | -25.28% | — | — | -0.03 | — | — | — | |
| FCHS 2nd | First Choice Healthcare Solutions | $329.58K | 0.01 | +0.00% | +0.00% | — | -7.00Mn | -0.05 | — | — | — | |
Showing 30 of 40 Generic Drugs companies
Create a free account to see the remaining 10, sort the full list on any column, and choose your own metrics.
Free, no card. Already have an account? Sign in.
No companies match that filter.
- 2nd a substantial business here, but not the company’s largest
- Prices and market caps as of the last close
- Click any column heading to sort
About this list
How many Generic Drugs stocks are there?
This list holds 40 US-listed companies, of which 23 have Generic Drugs as their primary business. The rest operate a substantial Generic Drugs business alongside something else, which is why they appear here as well as on their own primary list.
How is this list put together?
Every US-listed company is classified under BQ-MICS, our own multi-industry classification system. Unlike a single-label scheme it assigns each company a primary industry AND any secondary industries it genuinely operates in, and it records the reasoning behind every assignment — which you can read on each row of the table above.
Why do some companies appear on more than one list?
Because they genuinely operate more than one business. A retailer running a large cloud division belongs on both lists, and a classification that forces it onto one is hiding half the company. Every appearance beyond the primary one is labelled as secondary, and the toggle above the table hides them if you only want pure plays.
How often is this list updated?
Prices, market caps and performance figures refresh with each session's close. The classification itself is reviewed whenever a company's filings change what it does — a new segment, a disposal or an acquisition — rather than on a fixed calendar.
Can I screen these companies on other metrics?
Yes. Use Edit Columns above the table to add any of 1,000+ financial metrics and ratios to this list, or open the full stock screener to filter the whole market on them.